{"name":"Tr1X, Inc.","slug":"tr1x-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxQMGRrRTE4OF9PclZWUEdreC1vNGhGMURrVFdkTEVjWXkxX09NU2dNdk5LRThoSVdMU1hkUU5MQWhmcjdaNWpKMlNac0VvMklRZmdBZ1hDb2N4cU9rNlBXTmdMUUJvSEpwc3VWdFNzVF9EeUNCZnFpaUFXb2o3TG1CanptZlIzeUdSMFZFUlJRUHBBUTZ1a0NFR2RtU0ZGX2dvYUNHb1FMTjM0emh5TTNZSnFxYXhSVVQ3d3dZYTY3XzFlY2tHYno3aHdfc29qZHVqS3pjTXpqSDRLMEFXNDA3dnBhdlFZbjFBY21UYldHQmF4bHhXcVlTaWJvd1RPQy14OHlGdzdMSllMazV0MHN3Nm1xMXJDazVrRjQyWkprY1Y3a09fWUxiU3g2NUpFekV5b1I1bw?oc=5","date":"2026-02-04","type":"regulatory","source":"businesswire.com","summary":"Tr1X Presents First Clinical Data Demonstrating Proof of Safety and Proof of Mechanism With Allogeneic Off-the-Shelf Tr1 Regulatory T Cell Therapy TRX103 - businesswire.com","headline":"Tr1X Presents First Clinical Data Demonstrating Proof of Safety and Proof of Mechanism With Allogeneic Off-the-Shelf Tr1","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQUlU2MlJCazRtdXJhVFN6cUM2dTM3TkgwVGNiWkRHSlJ2aUNmTXhSV201Zm5rOUlfcTNCQWVPaVIwNW9iUkdDdE80ZFVLTkVXd2Y4ZmR0OVUxUWZ5N1NFU3BiVFVCQ2lkYWhUdkZlX2V2azhaY1ZmeVpaT3Z0LTRRdWtwQWMyMDB2QWlRT3NsalNfdHJ4aDg4bUYzV3lCaUVn?oc=5","date":"2025-10-15","type":"pipeline","source":"CGTLive®","summary":"Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025 - CGTLive®","headline":"Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025 - CGTLive®","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-14","type":"regulatory","source":"GlobeNewswire","summary":"Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Progressive Multiple Sclerosis, and $50 Million in Additional Financing - GlobeNew","headline":"Tr1X Announces FDA Clearance of IND Application for TRX319, a First-in-Class Allogeneic CAR-Tr1 Treg Cell Therapy for Pr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNVlVzaXpxcFNpenp2MXdKMW1EOGluYzBSRHFmV2k0d3oxbnQ5NGEzdDRsY3Q2WmN6SUd3T043c1VHVGlHeTNLR0x0N3BhQUpKRVg0RENoUDJWVTk5VjJJajdhc2xEZnZCODR3aEZmckIxanhObkszaHNBSUczcWhCaWFOTDN2RXdhaGptRGF1aGxEbWlGcWdrdko1SWppNE80VmtXZ0JJbWtqZw?oc=5","date":"2025-10-07","type":"pipeline","source":"BioSpace","summary":"BioSpace Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit - BioSpace","headline":"BioSpace Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNZ0FYdGhhUDU4MXM1ajltR2VaeWdIWHNmb2JqeFZuNWd5OENQTjBHbFhDVFF3eGRWMmlDaDcyYm1DRS1sNE5mQkI5Q3RJVEdaWm5WSGtibmZnb1d3bFdFY0FPdDZoNWtHX3VibXJ2Q2lWdUNlbHFfeVp4T0Z0aHQ4N09kOUk2SklDdURad3lqcUswaktuZnJFaHE5eEJZX3RjUE40WGlLQVRDM2RzNndpUmN3dXdrNm1pS3hsRVlkT2FlNHRkNmM1WTZNX19pVjNINHRXdGQxZmdBTENoY3ljUW40OUJpNjJhY0tLMzdlOWlKQlhER2RtanlLZkRiUkVUNVdJOWlrampuTjlfZFBTRG1UZ09lb29kaGF3NnVWcnJXdC1Ibm9oSDVEb2o3Tkoxb0lCZw?oc=5","date":"2024-04-10","type":"regulatory","source":"PR Newswire","summary":"Tr1X Announces FDA Clearance of First Investigational New Drug Application for TRX103, an Allogeneic Regulatory T-Cell Therapy to Treat Autoimmune Diseases - PR Newswire","headline":"Tr1X Announces FDA Clearance of First Investigational New Drug Application for TRX103, an Allogeneic Regulatory T-Cell T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPM2s4MjcxUmE5ZlJGcE96TVpjZnp4QVV0cy1INWhnMmsyYjBQVkpvTm1oUjdTWWk0cTV1RWxoVjJzRV8tQjc3WkYySlQ3ZWQ2dERGY3B0X2NDUmxmZEJYQ0owcXNrSlRQMFVoVWlLdnlVUmUzMl85bTJCT01zQkNWRGxqSE9FMmg1T0FV?oc=5","date":"2024-01-29","type":"pipeline","source":"San Diego Business Journal","summary":"Tr1X Secures $75M Series A - San Diego Business Journal","headline":"Tr1X Secures $75M Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxObVlyTUMyb3YzbndfWEpJN3pteU5IQVBxQ3R5Ym1OOVRJVkJCaTVBUmZuQVNDajU2dlRJVjBsamVoM3Z4c282ZVZNdzlxdVdmVHpPZHl6Nk51aEpRTFZIUkExZnZzYk1yREdvZDl4SldsejJ3MHRCNWhoNmdQQXlQWFNsdW9HYnRT?oc=5","date":"2024-01-19","type":"pipeline","source":"pharmaphorum","summary":"BridgeBio raises $1.25bn, and other biotech financings - pharmaphorum","headline":"BridgeBio raises $1.25bn, and other biotech financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPX0dfdWxBSXVCRVYzMkNka0xUa2c5UEx4RkowLTdRMlZaV2FCSGxBNjdLQUF2YUFyWDhwLThmVWo5SWtQWDVSR3lRSGQxdkstbTJmeVh0Q3YycmJ5cTM5c25JRDM4TnNidDV2RTB2ZWZQTk5pSDl4MnVqdHhZX0t0Y3U5b2x4QWJJ?oc=5","date":"2024-01-17","type":"pipeline","source":"BioPharma Dive","summary":"Tr1x, a new biotech, joins ‘Treg’ chase with $75M fundraise - BioPharma Dive","headline":"Tr1x, a new biotech, joins ‘Treg’ chase with $75M fundraise","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2024-01-17","type":"regulatory","source":"PR Newswire","summary":"Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammat","headline":"Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) an","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOWFlPY29ZRVphMjhOZkt4NERpZHhJb01FaldWdTk3XzFONUtKa192VjdhYzEtY3hTZTFWeEYwMWZ2cWQxY281WU14Nm8yZlpUTVpmUUhrNzBCYkpEOTQtSnNVV2VwNHhUVnJzYXVjN1lMRi1RdklVd0xMUnlzcHNZaVhaeVk3aFJ2MzJmTU90NlVCaHVHVnNsZDlaMVZscXZlMVZHQU1MWGFTTUNnSFBHd2Nn?oc=5","date":"2024-01-17","type":"pipeline","source":"MedCity News","summary":"Cell Therapy Startup With Stanford Roots Unveils $75M to Seek Inflammation Cures - MedCity News","headline":"Cell Therapy Startup With Stanford Roots Unveils $75M to Seek Inflammation Cures","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}